February issue reader poll
Gestational diabetes: Should you use oral agents?
Most relevant: 77%
Somewhat relevant: 3%
Least relevant: 20%
Examining the evidence on vitamin D, calcium, and CVD risk
Most relevant: 14%
Somewhat relevant: 75%
Least relevant: 11%
Oral contraceptives: What you need to know about the latest formulations
Most relevant: 55%
Somewhat relevant: 33%
Least relevant: 12%
Clinical Insights:
Infection resistance dips during ovulation
Most relevant: 11%
Somewhat relevant: 58%
Least relevant:31%
Twins from IVF help each other survive in utero
Most relevant: 31%
Somewhat relevant: 39%
Least relevant: 30%
US obesity rates: astronomical but leveling
Most relevant: 31%
Somewhat relevant: 39%
Least relevant: 30%
Moderately preterm infants have more emotional issues
Most relevant: 50%
Somewhat relevant: 47%
Least relevant: 3%
Smartphones may increase risk of health data breaches
Most relevant: 20%
Somewhat relevant: 69%
Least relevant: 11%
HHS overrules expanded availability of Plan B
Most relevant: 33%
Somewhat relevant: 47%
Least relevant: 20%
Legally Speaking: Lack of informed consent alleged after elective induction of labor
Most relevant: 67%
Somewhat relevant: 25%
Least relevant: 8%
SMFM Consult: Pregnancy in women with spinal cord injuries
Most relevant: 22%
Somewhat relevant: 55%
Least relevant: 23%
Meeting Coverage: ASRM takes on fertility knowledge gap, ‘personhood’ legislation
Most relevant: 19%
Somewhat relevant: 58%
Least relevant: 23%
Single iron infusion in late pregnancy significantly reduces anemia risk
January 22nd 2025A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.
Read More
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More